Related references
Note: Only part of the references are listed.Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer
Nobuyuki Kosaka et al.
CANCER SCIENCE (2010)
Dual-Modality Molecular Imaging Using Antibodies Labeled with Activatable Fluorescence and a Radionuclide for Specific and Quantitative Targeted Cancer Detection
Mikako Ogawa et al.
BIOCONJUGATE CHEMISTRY (2009)
In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring
W. Zhong et al.
BRITISH JOURNAL OF CANCER (2009)
In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies
Mikako Ogawa et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy
DM Goldenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Monoclonal antibody successes in the clinic
JM Reichert et al.
NATURE BIOTECHNOLOGY (2005)
Herceptin-geldanamycin immunoconjugates: Pharmacokinetics, biodistribution, and enhanced antitumor activity
R Mandler et al.
CANCER RESEARCH (2004)
Photosensitizer-antibody conjugates for detection and therapy of cancer
GAMS van Dongen et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Current clinical and preclinical photosensitizers for use in photodynamic therapy
MR Detty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Immunotherapy: past, present and future
TA Waldmann
NATURE MEDICINE (2003)
Clinical use of monoclonal antibody HuJ591 therapy: Targeting prostate specific membrane antigen
DM Nanus et al.
JOURNAL OF UROLOGY (2003)
Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates
M Carcenac et al.
BRITISH JOURNAL OF CANCER (2001)